Marshall Wace »

Catalyst Pharmaceutical Partners shares owned by Marshall Wace

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Marshall Wace from 13F filings

Historical chart of Marshall Wace investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Marshall Wace consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Marshall Wace

Quarter filed Position value Share count Share price at filing
2024-03-31 $27M 1.7M 15.94
2023-09-30 $865k 74k 11.69
2023-06-30 $2.6M 194k 13.44
2021-12-31 $1.4M 200k 6.77
2021-03-31 $476k 103k 4.61
2020-12-31 $474k 142k 3.34
2020-09-30 $882k 297k 2.97
2020-06-30 $1.5M 329k 4.62
2020-03-31 $4.3M 1.1M 3.85
2019-12-31 $5.9M 1.6M 3.75

More positions owned by Marshall Wace

Ishares-s&p 500 Etp (IVV)
Amazon.com Common Stock (AMZN)
Microsoft Corp Common Stock (MSFT)
Alphabet Inc-a Common Stock (GOOGL)
Apple Common Stock (AAPL)
Nvidia Corp Common Stock (NVDA)
Vanguard S&p 500 Etp (VOO)
Alphabet Inc-c Common Stock (GOOG)
Spdr S&p 500 Etf Equity Option Put Option (SPY)
Danaher Corp Common Stock (DHR)
Meta Platforms-a Common Stock (META)
Netflix Common Stock (NFLX)
Costco Wholesale Common Stock (COST)
Procter & Gamble Common Stock (PG)
Adv Micro Device Common Stock (AMD)

View all positions for Marshall Wace

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Deerfield Management Company
Vanguard Group
Dimensional Fund Advisors
Henderson Group
Geode Capital Management
Royce & Associates
Morgan Stanley
Marshall Wace
Robeco Investment Management
Northern Trust
Jacobs Levy Equity Management
T. Rowe Price Associates
Citadel Advisors
Voloridge Investment Management

View all funds holding Catalyst Pharmaceutical Partners